From: Changes in ovarian cancer survival during the 20 years before the era of targeted therapy
2005–2009 (n = 6317) | 2010–2014 (n = 7960) | p-value | |
---|---|---|---|
Age | |||
Early stagea | 81.5 | 86.3 | <.0001 |
< 40 | 89.1 | 91.6 | 0.203 |
40–59 | 83.9 | 88.1 | <.0001 |
> 59 | 66.8 | 77.0 | 0.001 |
Distant stage | 38.7 | 43.9 | <.0001 |
< 40 | 46.2 | 44.7 | 0.808 |
40–59 | 44.9 | 50.5 | <.0001 |
> 59 | 28.2 | 34.1 | 0.002 |
Surgery | |||
Early stagea | 81.5 | 86.3 | <.0001 |
with surgery | 82.6 | 87.1 | <.0001 |
without surgery | 62.3 | 60.7 | 0.383 |
Distant stage | 38.7 | 43.9 | <.0001 |
with surgery | 42.5 | 47.6 | <.0001 |
without surgery | 24.0 | 27.2 | 0.413 |